2019 Presenting Companies
Congratulations to the first round of presenting companies - the full list of thirty companies will be announced mid-July

Pharmaceutical
Boulder, CO
Aktivax is a Specialty Pharma company developing a range of drug products in proprietary prefilled drug delivery systems, focused on improving safety, usability, and drug stability.
Pharmaceutical
Louisville, CO
AmideBio is a preclinical stage biotech company pursuing a series of therapeutic targets and diagnostic in the diabetes space. The companies lead program is focused on novel forms of glucose responsive insulins (GRIs) that will eliminate the need for both basal and prandial insulins through a single weekly dose.
Biotechnology
Tucson, AZ
Aqualung Therapeutics (ALT) is an early stage, biotech company that is developing eNamptor™, a humanized immune-focused therapeutic monoclonal antibody (mAb) designed to reduce mortality in acute and chronic inflammatory disorders
Diagnostic
Boulder, CO
Brava Diagnostics is developing a highly sensitive in vitro diagnostic point-of-care platform for the acute care market. Brava's first product will be a high-sensitivity troponin test for diagnosis of heart attack.

Digital Health
Denver, CO
ClinOne is a suite of technologies created to improve access to mission-critical clinical study details, manage research site workflow, and provide patients with a solution to manage the clinical trial journey. 

Medical Device
Denver, CO 
 IMIDEX uses cutting-edge predictive analytics to distill all of that chaos into meaningful insights and actionable guidelines.  IMIDEX  is developing and curating a contributory database of radiological images that serve as the foundation of machine learning algorithms that achieve increased accuracy at identifying radiological findings. 

Biotechnology
Denver, CO
ImmunoMolecular Therapeutics (IMT) is a precision medicine company focused on developing targeted oral, small molecule drugs for treating autoimmune diseases, developing personalized immuno-therapeutic drugs based on the genetic risk attributed by human leukocyte antigen (HLA) genes. 

Diagnostic
Longmont, CO
KromaTiD, Inc. is a commercial stage genomic analysis company creating proprietary and unique products for the single-cell detection and quantitation of genomic structural variation associated with gene editing, undiagnosed genetic diseases and other applications.
Diagnostic
Boulder, CO 
An early stage medical device company that manufactures proprietary in vitro diagnostic (IVD) devices. Our devices enable consumers to monitor fertility, detect hormonal imbalances that cause infertility and miscarriage, and treat infertility at home with Proov® rapid response.
Biotechnology
Tucson, AZ
MVT develops the next generation of contrast agents for diagnostic ultrasound and advance the field of ultrasound for diagnosis and treatment of disease. The founders of MVT developed the world’s #1 selling ultrasound contrast agent, Definity®.  MVT has developed a new, patented fomulation, MVT-100 for use as ultrasound contrast agent.
Neuraptive Therapeutics Biotechnology
Lafayette, CO
Neuraptive is developing a suite of products for use during microsurgical repair of peripheral nerves. The Company's franchiese product, AxoFuse, is a novel therapeutic for use as an adjunct to standard nerve surgical repair. The additional products in the Company's pipeline provide surgeons with instruments that improve speed and consistency to procedures
Medical Device 
Salt Lake City, UT
The ReddyPort oral access elbow provides simple, yet crucial, oral access through non-invasive positive pressure ventilation (NIV) masks while maintaining therapeutic pressure. The ReddyPort system includes the elbow and other products configured to work with the elbow, including an oral care kit, patient microphone, nebulizer, capnography adapter, and endoscopy adapter.
Pharmaceutical
Boulder, CO
Sinfonia Biotherapeutics is pioneering the development of novel, bioreactor-delivered drug treatments for familial & genetically-defined orphan neurodegenerative disorders within frontotemporal lobar dementia (FTD), Alzheimer’s and Parkinson’s disorders.